Attempted Eradication of PRRS Virus, Enzootic Pneumonia, Actinobacillus Pleuropneumonia and Streptococcal Meningitis

The farm was a closed herd using AI and comprised 430 breeding sows. Progeny were kept until 10 weeks of age when they were sent to a second unit for finishing. The farm was infected with PRRS virus, as well as enzootic pneumonia (EP) (Mycoplasma hyopneumoniae), pleuropneumonia (Actinobacillus pleuropneumoniae) (APP) and streptococcal meningitis/arthritis (SM) (Streptococcus suis). The farm was planning to replace the weaning accommodation hence an opportunity arose to depopulate the farm’s growing animals and to focus on eradication procedures in the breeding stock. The finishing site was also depopulated.

Gilts at 6 months of age were stockpiled from the finishing house prior to the start of the programme. They were vaccinated against M. hyopneumoniae and given tulathromycin (Draxxin® – Zoetis) to resolve ongoing respiratory infections and encourage lung lesions to heal. All of the breeding stock were injected with a killed PRRSV vaccine (Progressis® – Merial) initially and this was followed at monthly intervals with two live PRRSV vaccinations (Porcilis PRRS – MSD). When all the new gilts were 10 months of age, the whole breeding herd was treated with tiamulin (Denagard®– Elanco) in feed at 10mg/kg bwt for 4 weeks to eliminate M. hyopneumoniae. As the strain of APP was shown to be resistant to macrolides, marbofloxacin (Forcyl® – Vetoquinol) by injection was used to eliminate the organism in the last week of medication. A further two weeks in-feed medication was given containing trimethoprim/sulfadiazine (Trimediazine® – Vetoquinol) at 15mg/kg bwt to support the elimination of APP and possibly S. suis. Piglets were injected with tulathromycin on a weekly basis and weaned off site until the piglets from the tiamulin and TMP/S medicated sows came through. Piglets were monitored for PRRSV and M. hyopneumoniae by PCR, using saliva and pooled blood samples. Lungs were regularly checked for lesions at slaughter, at approximately 6 month intervals.

Lung lesion scores were compared from before (18/9/2013) and after the programme (19/6/2015). EP-like lesion scores had fallen from 4.91 to 0; APP lesions had fallen from 6.8% to 0%; pleurisy had declined from 36.7% to 7.9%; pericarditis had increased from 2% to 5.9%. The S. suis infection rapidly returned and still required treatment.

Three common respiratory infections (PRRSV, EP & APP) were eradicated by focusing on vaccination and treatment of the breeding herd. Biosecurity was also improved by restricting access to the site of vehicles and personnel, to try to prevent re-infection and the programme has been successful for the last 18 months.

Disclosure of Interest: D. Burch: None Declared, B. Bremner: None Declared, C. O'Neill Conflict with: Employee, U. Klein Conflict with: Employee.